RSM logo
Journal of Medical Screening

Home Current issue Browse archive Alerts About the journal Feedback
 
J Med Screen 2008;15:153-158
doi:10.1258/jms.2008.008052
© 2008 Medical Screening Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berrington de González, A.
Right arrow Articles by Berg, C. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Articles

Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk

Amy Berrington de González, Investigator , Division of Cancer Epidemiology & Biostatistics, National Cancer Institute, Bethesda, MD, USA

Kwang Pyo Kim, Research Fellow , Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA

Christine D Berg, Group Chief  , Early Detection Research Group, National Cancer Institute, Bethesda, MD, USA

Correspondence to: Amy Berrington de González, Radiation Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Bethesda, MD 20892, USA; berringtona{at}mail.nih.gov


Objectives To estimate the risk of radiation-induced lung cancer mortality from three annual low-dose lung computed tomography (CT) screens before age 55 years (starting at age 30, 40 or 50) and the mortality reduction from screening (i.e. the efficacy) needed to outweigh these risks for never and current-smokers. The risk of radiation-induced breast cancer was also estimated for women.

Methods The Biological Effectiveness of Ionizing Radiation VII committee's risk models were used to estimate radiation risk. Lung cancer mortality rates (based on the Bach model for current and the Cancer Prevention Study for never-smokers) were used to estimate the mortality reduction needed to outweigh this risk.

Results For never-smokers, the estimated excess lifetime risk of radiation-induced lung cancer mortality from annual screening aged 40–42 was 1/10,000 (90% credibility interval: 0.4–3) for men and 3/10,000 (2–6) for women. For current-smokers, the estimated risks were approximately two-fold higher, with wider credibility intervals. Risks from screening age 30–32 or 50–52 years were of similar magnitude. The mortality reduction required to outweigh these risks was, for female never-smokers: 125% (40–300%) age 30–32 years, 70% (30–190%) age 40–42 years and 25% (10–70%) age 50–52 years, and for male current-smokers: 70% (20–120%) age 30–32 years, 10% (3–20%) age 40–42 years and 2% (1–4%) age 50–52 years. These figures were two to three times higher for females because of the higher radiation risks. The risk of radiation-induced breast cancer was in the range of three to six cases/10,000 females screened.

Conclusion Before age 50, the mortality reduction from lung CT screening that is required to outweigh the radiation risk may be substantial, and in some cases unattainable (i.e. >100%).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




MDU Exam Doctor